124 related articles for article (PubMed ID: 2944207)
1. [Methods of extracorporeal therapy of rheumatic diseases].
Shilkina NP; Pukhov AG
Revmatologiia (Mosk); 1986; (2):57-63. PubMed ID: 2944207
[No Abstract] [Full Text] [Related]
2. [Gene therapy in autoimmune rheumatic diseases].
Sekigawa I; Ogasawara H; Hirose S
Nihon Rinsho; 1999 Feb; 57(2):449-53. PubMed ID: 10078022
[TBL] [Abstract][Full Text] [Related]
3. [Immunopathology of the skin and hemosorption].
Beletskaia LV; Dmitriev AA; Petrova GN; Bukhova VP; Mudrenko IIu
Vestn Dermatol Venerol; 1985 May; (5):15-8. PubMed ID: 2930959
[No Abstract] [Full Text] [Related]
4. [Changes in physico-chemical properties of immune complexes during hemosorption].
Struchkov PV; Konstantinova NA; Chuchalin AG; Evseev NG; Shurkalin BK
Sov Med; 1985; (1):35-9. PubMed ID: 3157221
[No Abstract] [Full Text] [Related]
5. [Extracorporeal immunosorption].
Lopukhin IuM; Kulaev DV
Ter Arkh; 1985; 57(10):65-71. PubMed ID: 2934846
[No Abstract] [Full Text] [Related]
6. [Plasmapheresis therapy. Immunopathologic concepts].
Rother K; Thies K
Internist (Berl); 1983 Jan; 24(1):1-13. PubMed ID: 6220993
[No Abstract] [Full Text] [Related]
7. [Changes in the functional activity of neutrophils during hemosorption therapy of patients with systemic rheumatic and other diseases with immunologic disorders].
Mogireva IA; Barsukov AA; Dmitriev AA; Zemskov VM
Ter Arkh; 1985; 57(8):30-3. PubMed ID: 2933840
[TBL] [Abstract][Full Text] [Related]
8. [Future research for the treatment of intractable diseases].
Mizushima Y
Ryumachi; 1995 Dec; 35(6):877-9. PubMed ID: 8720264
[No Abstract] [Full Text] [Related]
9. [Recent developments in high-dose immunoglobulin therapy: therapeutic plasma exchange, autoimmune diseases].
Kalden JR; Schranz W; Lösch G; Krapf F; Bartels O
Beitr Infusionther Klin Ernahr; 1982; 9():48-59. PubMed ID: 6216881
[No Abstract] [Full Text] [Related]
10. Methods available for plasma component removal.
Smith JW
Trans Am Soc Artif Intern Organs; 1984; 30():694-5. PubMed ID: 6241972
[No Abstract] [Full Text] [Related]
11. [Extracorporeal immunocorrection].
Lopukhin IuM; Kulaev DV; Koval'chuk LV
Klin Med (Mosk); 1986 Mar; 64(3):11-7. PubMed ID: 2940414
[No Abstract] [Full Text] [Related]
12. Indications and limitations of therapeutic plasmapheresis.
Kater L
Neth J Med; 1981; 24(6):206-8. PubMed ID: 6459532
[No Abstract] [Full Text] [Related]
13. [Plasmapheresis--therapeutic aspects].
Wiecek A; Grzeszczak W
Postepy Hig Med Dosw; 1987; 41(2):152-69. PubMed ID: 3313328
[No Abstract] [Full Text] [Related]
14. [Prophylaxis and treatment of states of antibody deficiency and of autoimmunity].
Albores JM; Cedrato AE
Minerva Pediatr; 1966 Oct; 18(29):1652-90. PubMed ID: 4171472
[No Abstract] [Full Text] [Related]
15. Management of immune-mediated and paraproteinemic diseases by membrane plasma separation and cascade filtration.
Valbonesi M; Garelli S; Montani F; Cefis M; Rossi U
Vox Sang; 1982; 43(2):91-101. PubMed ID: 6214891
[TBL] [Abstract][Full Text] [Related]
16. [Active pathogenetic therapy of systemic rheumatic diseases].
Nasonova VA
Ter Arkh; 1985; 57(8):3-6. PubMed ID: 4071432
[No Abstract] [Full Text] [Related]
17. [Recent conception of collagen diseases].
Yamamoto K
Nihon Rinsho; 1999 Feb; 57(2):257-61. PubMed ID: 10077987
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic plasma exchange: indications and results].
Roujeau JC; Quaranta JF; Guillevin L; Cassuto JP; Chalopin JM; Gajdos P; Sobel A; Rifle G
Ann Med Interne (Paris); 1984; 135(4):308-27. PubMed ID: 6236729
[No Abstract] [Full Text] [Related]
19. [Plasmapheresis in the treatment of diseases caused by immunologic pathology].
Gorodetskiĭ VM; Ryzhko VV
Ter Arkh; 1984; 56(6):19-23. PubMed ID: 6236574
[TBL] [Abstract][Full Text] [Related]
20. [Plasma- and lymphapheresis in autoimmune diseases].
Schneider M
Z Rheumatol; 1996; 55(2):90-104. PubMed ID: 8686387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
